• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织病理学、血清学及分子学检查结果在麻风病治疗失败早期诊断中的作用

Role of histopathological, serological and molecular findings for the early diagnosis of treatment failure in leprosy.

作者信息

de Carvalho Dornelas Bruno, da Costa Willian Vargas Tenório, de Abreu João Pablo Ferraz, Daud Juliana Salomão, Campos Felipe Dos Anjos Rodrigues, de Oliveira Campos Deiriene Rodrigues, Antunes Douglas Eulálio, de Araújo Lúcio Borges, Dos Santos Diogo Fernandes, Soares Cleverson Teixeira, Goulart Isabela Maria Bernardes

机构信息

Pathology Unit, Hospital of Clinics, Federal University of Uberlândia, Brazilian Company for Hospital Services (HC-UFU/EBSERH), Uberlândia, MG, Brazil.

Post-Graduation Program in Health Science, School of Medicine, Federal University of Uberlândia, Uberlândia, MG, Brazil.

出版信息

BMC Infect Dis. 2024 Oct 1;24(1):1085. doi: 10.1186/s12879-024-09937-2.

DOI:10.1186/s12879-024-09937-2
PMID:39354399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11443919/
Abstract

BACKGROUND

Treatment failure (TF) in leprosy following multidrug therapy (MDT) presents a significant challenge. The current World Health Organization (WHO) fixed-duration MDT regimen, based on lesion count, might not be adequate. Leprosy lacks clear-cut objective cure criteria, and the predictive value of post-MDT histopathological findings remains uncertain. This study aims to identify predictive factors for TF among leprosy patients who have completed the WHO-recommended MDT.

METHODS

An analysis was conducted on 80 individuals from a national leprosy reference center, comprising 40 TF cases (with a mean relapse at 13.0 months) and 40 controls (with a mean of 113.1 months without disease signs). Various epidemiological and clinical-laboratory parameters were assessed post-MDT.

RESULTS

In skin samples, the presence of foamy granuloma (OR = 7.36; 95%CI2.20-24.60; p = 0.0012) and histological bacillary index (hBI) ≥ 1+ (OR = 1.55; 95%CI1. 22-1.99; p = 0.0004) were significantly associated with TF, with odds ratios of 7.36 and 1.55, respectively. Individuals who experienced TF had a mean hBI of 3.02+ (SD ± 2.02), while the control group exhibited a mean hBI of 1.8+ (SD ± 1.88). An hBI ≥ 3 + showed a sensitivity of 73% and a specificity of 78% for TF detection (AUC: 0.75; p = 0.0001). Other histopathological features like epithelioid granulomas, and skin changes did not show significant associations (p > 0.05). Additionally, higher anti-phenolic glycolipid-I (anti-PGL-I) ELISA index (EI) levels were linked to a 1.4-fold increased likelihood for TF (OR = 1.4; 95%CI1.13-1.74; p = 0.0019). A mean EI of 4.48 (SD ± 2.80) was observed, with an EI ≥ 3.95 showing a sensitivity of 79% and a specificity of 59% for TF detection (AUC: 0.74; p = 0.0001). Moreover, the presence of Mycobacterium leprae (M. leprae) DNA in real-time polymerase chain reaction (qPCR) was associated with a 3.43-fold higher likelihood of TF. Multivariate regression analysis indicated that concurrent presentation of neural/perineural lymphocytic infiltrate, foamy granuloma, hBI ≥ 1+, and EI ≥ 1 markedly increased the likelihood of TF by up to 95.41%.

CONCLUSION

Persistence of nerve-selective lymphocytic infiltrate, foamy granulomas, and bacilli in skin biopsies, and elevated EI post-MDT, may serve as predictive factors for identifying individuals at higher probability of TF.

摘要

背景

多药联合疗法(MDT)治疗麻风病后的治疗失败(TF)是一个重大挑战。目前世界卫生组织(WHO)基于皮损数量的固定疗程MDT方案可能并不充分。麻风病缺乏明确的客观治愈标准,MDT后组织病理学检查结果的预测价值仍不确定。本研究旨在确定已完成WHO推荐的MDT的麻风病患者中TF的预测因素。

方法

对一家国家麻风病参考中心的80名个体进行分析,其中包括40例TF病例(平均复发时间为13.0个月)和40名对照(平均113.1个月无疾病体征)。MDT后评估了各种流行病学和临床实验室参数。

结果

在皮肤样本中,泡沫状肉芽肿的存在(OR = 7.36;95%CI 2.20 - 24.60;p = 0.0012)和组织学细菌指数(hBI)≥1+(OR = 1.55;95%CI 1.22 - 1.99;p = 0.0004)与TF显著相关,比值比分别为7.36和1.55。发生TF的个体平均hBI为3.02+(标准差±2.02),而对照组平均hBI为1.8+(标准差±1.88)。hBI≥3+对TF检测的敏感性为73%,特异性为78%(曲线下面积:0.75;p = 0.0001)。其他组织病理学特征如上皮样肉芽肿和皮肤改变未显示出显著相关性(p > 0.05)。此外,较高的抗酚糖脂-I(anti-PGL-I)酶联免疫吸附测定(ELISA)指数(EI)水平与TF可能性增加1.4倍相关(OR = 1.4;95%CI 1.13 - 1.74;p = 0.0019)。观察到平均EI为4.48(标准差±2.80),EI≥3.95对TF检测的敏感性为79%,特异性为59%(曲线下面积:0.74;p = 0.0001)。此外,实时聚合酶链反应(qPCR)中麻风分枝杆菌(M. leprae)DNA的存在与TF可能性高3.43倍相关。多变量回归分析表明,神经/神经周围淋巴细胞浸润、泡沫状肉芽肿、hBI≥1+和EI≥1同时出现使TF可能性显著增加高达95.41%。

结论

皮肤活检中神经选择性淋巴细胞浸润、泡沫状肉芽肿和杆菌的持续存在,以及MDT后EI升高,可能作为识别TF可能性较高个体的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/68311b3d0044/12879_2024_9937_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/4acc8bb610df/12879_2024_9937_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/69340043f98a/12879_2024_9937_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/7569aeb74e75/12879_2024_9937_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/e5eb03cf87e6/12879_2024_9937_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/68311b3d0044/12879_2024_9937_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/4acc8bb610df/12879_2024_9937_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/69340043f98a/12879_2024_9937_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/7569aeb74e75/12879_2024_9937_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/e5eb03cf87e6/12879_2024_9937_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/11443919/68311b3d0044/12879_2024_9937_Fig5_HTML.jpg

相似文献

1
Role of histopathological, serological and molecular findings for the early diagnosis of treatment failure in leprosy.组织病理学、血清学及分子学检查结果在麻风病治疗失败早期诊断中的作用
BMC Infect Dis. 2024 Oct 1;24(1):1085. doi: 10.1186/s12879-024-09937-2.
2
Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.麻风病患者及其接触者不同类型临床样本中,PCR介导的DNA扩增与检测麻风分枝杆菌经典方法的比较。
Lepr Rev. 2003 Mar;74(1):18-30.
3
Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.多药联合化疗固定疗程24个月后涂片阳性麻风患者的鼻黏膜和皮肤:组织病理学及微生物学研究
Int J Lepr Other Mycobact Dis. 1999 Sep;67(3):292-7.
4
-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.多菌型麻风病患者在接受常规 12 剂量联合化疗(MDT)或统一 6 剂量 MDT 治疗期间和治疗后,特异性抗体减少。
Front Immunol. 2018 May 14;9:915. doi: 10.3389/fimmu.2018.00915. eCollection 2018.
5
Develop and Field Evolution of Single Tube Nested PCR, SYBRGreen PCR Methods, for the Diagnosis of Leprosy in Paraffin-embedded Formalin Fixed Tissues in Yunnan Province, a Hyper endemic Area of Leprosy in China.建立并现场应用单管巢式 PCR 和 SYBRGreen PCR 方法检测云南省石蜡包埋福尔马林固定组织中麻风分枝杆菌
PLoS Negl Trop Dis. 2019 Oct 2;13(10):e0007731. doi: 10.1371/journal.pntd.0007731. eCollection 2019 Oct.
6
The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.皮质类固醇使用对麻风病细菌杀灭、清除及神经损伤的影响;第3部分——对两组各100例多菌型(MB)患者的研究,一组接受多药联合化疗(MDT)+类固醇治疗,另一组仅接受MDT治疗,在完成12个月MDT停药6个月后进行评估。
Lepr Rev. 2010 Mar;81(1):41-58.
7
Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.瘤型麻风患者在治疗及随访过程中皮肤损害大小及数量的变化
Lepr Rev. 2011 Sep;82(3):244-52.
8
Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?在接受12个月和24个月的多药治疗后,瘤型麻风患者体内是否仍存在活的麻风分枝杆菌?
Indian J Lepr. 2004 Jul-Sep;76(3):199-206.
9
A study on the impact of FD-MDT on 200 leprosy patients.一项关于免费多药联合疗法对200例麻风病患者影响的研究。
Indian J Lepr. 2005 Jul-Sep;77(3):217-27.
10
Quantitative real-time PCR analysis of Mycobacterium leprae DNA and mRNA in human biopsy material from leprosy and reactional cases.对麻风病及反应性病例的人体活检材料中麻风分枝杆菌DNA和mRNA进行定量实时PCR分析。
J Med Microbiol. 2009 Jun;58(Pt 6):753-759. doi: 10.1099/jmm.0.007252-0.

引用本文的文献

1
Global Trends in the Incidence, Prevalence and Disability-Adjusted Life Years of Leprosy from 1990 to 2019: An Age-Period-Cohort Analysis Using the Global Burden of Disease Study 2019.1990年至2019年麻风病发病率、患病率及伤残调整生命年的全球趋势:基于2019年全球疾病负担研究的年龄-时期-队列分析
Clin Cosmet Investig Dermatol. 2025 Apr 9;18:883-898. doi: 10.2147/CCID.S508600. eCollection 2025.

本文引用的文献

1
Assessment of Clinical, Histopathological, and Bacteriological Findings in Treated Leprosy Patients with Persistent Skin Lesions: A Retrospective Cohort Study.评估治疗后麻风病患者持续皮肤损伤的临床、组织病理学和细菌学发现:一项回顾性队列研究。
Am J Trop Med Hyg. 2023 Nov 6;109(6):1260-1265. doi: 10.4269/ajtmh.23-0084. Print 2023 Dec 6.
2
High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.印度麻风分枝杆菌氧氟沙星耐药模式的高频率:重新审视二线抗麻风病治疗方案的指征。
J Glob Antimicrob Resist. 2023 Dec;35:262-267. doi: 10.1016/j.jgar.2023.10.006. Epub 2023 Oct 16.
3
Modulation of the Response to and Pathogenesis of Leprosy.
麻风病反应及发病机制的调节
Front Microbiol. 2022 Jun 2;13:918009. doi: 10.3389/fmicb.2022.918009. eCollection 2022.
4
Drug resistance in leprosy: An update following 70years of chemotherapy.麻风病耐药性:化疗 70 年后的最新进展。
Infect Dis Now. 2022 Aug;52(5):243-251. doi: 10.1016/j.idnow.2022.04.001. Epub 2022 Apr 26.
5
Correlation of Histomorphological Findings with Bacteriological Index in Leprosy Patients.麻风病患者组织形态学结果与细菌学指标的相关性
Iran J Pathol. 2022 Winter;17(1):48-55. doi: 10.30699/IJP.2021.534122.2682. Epub 2021 Dec 15.
6
Leprosy Relapse: A Retrospective Study on Epidemiologic, Clinical, and Therapeutic Aspects at a Brazilian Referral Center.麻风病复发:巴西一家转诊中心关于流行病学、临床和治疗方面的回顾性研究。
Int J Infect Dis. 2022 May;118:44-51. doi: 10.1016/j.ijid.2022.01.009. Epub 2022 Jan 10.
7
Assessment of neuropathic pain in leprosy patients with relapse or treatment failure by infrared thermography: A cross-sectional study.红外热成像评估复发或治疗失败的麻风病患者的神经病理性疼痛:一项横断面研究。
PLoS Negl Trop Dis. 2021 Sep 23;15(9):e0009794. doi: 10.1371/journal.pntd.0009794. eCollection 2021 Sep.
8
Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center.20 年队列研究显示,12 剂多药疗法治疗麻风病后复发率低:巴西参考中心的研究。
PLoS Negl Trop Dis. 2021 May 3;15(5):e0009382. doi: 10.1371/journal.pntd.0009382. eCollection 2021 May.
9
Persistent plaques after release from treatment in slit-skin smear negative leprosy patients: Wait and watch or adopt a proactive approach?皮肤涂片阴性麻风患者治疗结束后持续存在的斑块:等待观察还是采取积极主动的方法?
Dermatol Ther. 2020 Nov;33(6):e14226. doi: 10.1111/dth.14226. Epub 2020 Sep 17.
10
Clinicobacteriological evaluation of leprosy patients with 1-5 skin lesions.1-5 处皮损麻风病患者的临床细菌学评估。
Int J Mycobacteriol. 2020 Apr-Jun;9(2):209-211. doi: 10.4103/ijmy.ijmy_7_20.